Systemic lupus erythematosus in Indian patients: Prognosis, survival and life expectancy

National Medical Journal of India

Volumn 10, Issue 4, 1997, Pages 159-164

  Murali, R ^a   Jeyaseelan, L ^a   Rajaratnam, S ^a   John, L ^b   Ganesh, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b MANIPAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; HUMAN; INDIA; LIFE EXPECTANCY; MALE; MORTALITY; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS;

FEMALE; HUMANS; INDIA; LIFE EXPECTANCY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MARKOV CHAINS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0031182846     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Malaviya AN, Misra R, Kumar A, Tiwari SC. Systemic connective tissue diseases in India - IX. Survival in systemic lupus erythematosus. J Assoc Physicians India 1987;35:509-11.
2. Kumar A, Malaviya AN, Singh RR, Singh YN, Adya CM, Kakkar R. Survival in patients with systemic lupus erythematosus in India. Rheumatol Int 1992;12: 107-9.
3. Pothen J, Chandy M, Padmanabhan N, Richard J, Pulimood BM. Systemic lupus erythematosus: A study from South India. J Assoc Physicians India 1982;32: 495-9.
4. Feng PH, Boey ML. Systemic lupus erythematosus in Chinese: The Singapore experience. Rheumatol Int 1982;2:151-4.
5. Boey ML, Ng SC, Feng PH. Mortality of Orientals with systemic lupus erythematosus - A reappraisal. Singapore Med J 1987;28:318-20.
6. Cohen MG, Li EK. Mortality in systemic lupus erythematosus: Active disease is the most important factor. Aust N Z J Med 1992;22:5-8.
7. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612-17.
8. Lee P, Urowitz MB, Bookman AA, Koehler BE, Smythe HA, Gordon DA, et al. Systemic lupus erythematosus: A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 1977;46: 1-32.
9. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50:85-95.
10. Swaak AJ, Nossent JC, Bronsveld W, van Rooyen A, Nieunenhuys EJ, Theuns L, et al. Systemic lupus erythematosus I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989;48:447-54.
11. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus: Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
12. Gladman DD. Prognosis of systemic lupus erythematosus and factors that affect it. Curr Opin Rheumatol 1992;4:681-7.
13. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982;25:601-11.
14. Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: High prevalence, morbidity and mortality. Aust N Z J Med 1993;23:646-51.
15. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985;55:87-98.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992;35:630-40.
17. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardiere, Isenberg D, et al. Cross cultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992;19:608-11.
18. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992;19:53-9.
19. Hawker O, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman DD. A reliability study of SLEDAI: A disease activity index for systemic lupus erythematosus. J Rheumatol 1993;20:657-60.
20. Silverstein MD, Albert DA, Hadler NM, Ropes MW. Prognosis in SLE: Comparison of Markov model to life table analysis. J Clin Epidemiol 1988;41:623-33.
21. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Making a prognosis. In: Clinical epidemiology: A basic science for clinical medicine. Boston:Little Brown, 1991: 173-85, 366-7.
22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
23. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983;3:419-58.
24. Smith KR, Slattery KL, French TK. Collinear nutrients and the rise of colon cancer. J Clin Epidemiol 1991;44:715-23.
25. Mansfield ER, Helms BP. Detecting multicollinearity. Am Statist 1982;36:158-60.
26. Studenski S, Allen NB, Caldwell DS, Rice JR, Polisson RP. Survival in systemic lupus erythematosus: A multivariate analysis of demographic factors. Arthritis Rheum 1987;30:1326-32.
27. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socio-economic status. Am J Med 1991;91: 345-53.
28. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM. Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323-39.
29. Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992;19:47-52.
30. Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum 1991;21:73-80.
31. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 1991;21:55-64.
32. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL. Systemic lupus erythematosus - Survival patterns: Experience with 609 patients. JAMA 1981;245:934-8.
33. Nossent JC. Clinical renal involvement in Afro-Carribean lupus patients. Lupus 1993;2:173-6.
34. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994;330:1871-9.
35. McLaughlin JR, Bombardier C, Farewell VT, Gladman DD, Urowitz MB. Kidney biopsy in systemic lupus erythematosus. III. Survial analysis controlling for clinical and laboratory variables. Arthritis Rheum 1994;37:559-67.
36. McLaughlin JR, Gladman DD, Urowitz MB, Bombardier C, Farewell VT, et al. Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. Arthritis Rheum 1991;34:1268-73.
37. Bhuyan UN, Malaviya AN, Kumar R, Malhotra KK, Tandon HD. Frequency and severity of renal lesions in systemic lupus erythematosus in north India. Indian J Med Res 1977;66:965-73.
38. Samanta A, Roy S, Feehally J, Symmons DPM. The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester City. UK. Br J Rheumatol 1992;31:679-82.
39. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991;50:490-2.
40. Nossent JC. Course and prognostic value of systemic lupus erythematosus disease activity index in black Carribean patients. Semin Arthritis Rheum 1993;23:16-21.